What is the Return on Assets (ROA) of I-Mab this year?
The Return on Assets (ROA) of I-Mab is -0.1 undefined this year.
I-Mab ROA 2025
I-Mab ROA
-0.1
Ticker
IMAB
ISIN
US44975P1030
WKN
A2PVC6
In 2025, I-Mab's return on assets (ROA) was -0.1, a -81.68% increase from the -0.56 ROA in the previous year.
I-Mab Aktienanalyse
What does I-Mab do?
I-Mab is a Chinese biopharmaceutical company specializing in the development of innovative therapies for the treatment of cancer and autoimmune diseases. It was founded in 2016 by Dr. Jingwu Zang and is based in Shanghai, China. I-Mab's business model focuses on the development of antibody therapies tailored to the needs of cancer and autoimmune patients. They utilize the latest research and development to create therapies that address the unmet market demand. They work on cancer immunotherapy, including CAR-T cell therapy, and also on immunotherapy for autoimmune diseases, including rare ones. Their goal is to improve the lives of patients with cancer and autoimmune diseases through innovative biotechnology and research. They have promising products in development and clinical trials, such as AMG 228 and TJM2. They aim to make a significant contribution to healthcare with their dedicated team of researchers and scientists. I-Mab ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROA Details
Understanding I-Mab's Return on Assets (ROA)
I-Mab's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.
Year-to-Year Comparison
Comparing I-Mab's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.
Impact on Investments
Investors consider I-Mab's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.
Interpreting ROA Fluctuations
Variations in I-Mab’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.
Frequently Asked Questions about I-Mab stock
What was the ROA of I-Mab compared to the previous year?
The ROA of I-Mab has increased by -81.68% compared to the previous year.
What consequences do high ROA have for investors of I-Mab?
A high ROA is advantageous for investors of I-Mab, as it indicates that the company efficiently utilizes its assets and generates good profits.
What are the consequences of low ROA for investors in I-Mab?
A low ROA can be unfavorable for investors of I-Mab as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.
How does an increase in the ROA of I-Mab affect the company?
An increase in ROA of I-Mab can be an indicator of improved efficiency in asset utilization and higher profitability.
How does a reduction in ROA of I-Mab impact the company?
A reduction in the ROA of I-Mab can be an indicator of lower asset efficiency and profitability.
What are some factors that can influence the ROA of I-Mab?
Some factors that can influence the ROA of I-Mab include revenue, operating costs, asset structure, and industry average.
Why is the ROA of I-Mab important for investors?
The ROA of I-Mab is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.
What strategic measures can I-Mab take to improve ROA?
To improve ROA, I-Mab can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.
How much dividend does I-Mab pay?
Over the past 12 months, I-Mab paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, I-Mab is expected to pay a dividend of 0 USD.
What is the dividend yield of I-Mab?
The current dividend yield of I-Mab is .
When does I-Mab pay dividends?
I-Mab pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of I-Mab?
I-Mab paid dividends every year for the past 0 years.
What is the dividend of I-Mab?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is I-Mab located?
I-Mab is assigned to the 'Health' sector.
Wann musste ich die Aktien von I-Mab kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of I-Mab from 10/8/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/8/2025.
When did I-Mab pay the last dividend?
The last dividend was paid out on 10/8/2025.
What was the dividend of I-Mab in the year 2024?
In the year 2024, I-Mab distributed 0 USD as dividends.
In which currency does I-Mab pay out the dividend?
The dividends of I-Mab are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von I-Mab
Our stock analysis for I-Mab Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of I-Mab Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
